%D9%83%D8%A7%D8%B3%D8%A8%D9%88%D9%81%D9%86%D8%AC%D9%8A%D9%86%DA%A9%D8%B3%D9%BE%D9%88%D9%81%D8%A7%D9%86%D8%AC%DB%8C%D9%86CaspoffwnginCaspofunginCaspofunginCaspofungina%DA%A9%D8%B3%D9%BE%D9%88%D9%81%D8%A7%D9%86%D8%AC%DB%8C%D9%86Caspofungine%D7%A7%D7%A1%D7%A4%D7%95%D7%A4%D7%95%D7%A0%D7%92%D7%99%D7%9FCaspofunginaCaspofunginKaspofunginaCaspofunginaCaspofungin%C4%83KaspofunginKaspofungin%D0%9A%D0%B0%D1%81%D0%BF%D0%BE%D1%84%D1%83%D0%BD%D0%B3%D1%96%D0%BDQ420875
about
P3781
A Study of Caspofungin Acetate (MK0991) for the Treatment of Esophageal Candidiasis or Invasive Candidiasis in Chinese Adults (MK-0991-066)Antimicrobial PK in Infants With Suspected or Confirmed InfectionCaspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell TransplantCaspofungin Based Combined Anti-fungal Therapy for Proven or Probable Invasive Fungal InfectionOptimal Dosage of Caspofungin in Critically Ill PatientsPharmacokinetics of Caspofungin After One Dose in Patients With Liver FailureProphylaxis of Fungal Invasive Infections in LeukemiaCaspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell TransplantStudy of Micafungin in Patients With Invasive Candidiasis or CandidemiaCaspofungin for the Treatment of Non-blood Candida Infections (0991-045)Efficacy and Safety of Caspofungin for Invasive Pulmonary Aspergillosis Underlying Chronic Obstructive Pulmonary DiseasePharmacokinetics of CaspofunginStudy of Rezafungin Compared to Caspofungin in Subjects With Candidemia and/or Invasive CandidiasisPharmacokinetics/Pharmacodynamics (PK/PD) of Caspofungin in Intensive Care Unit (ICU) Patients. An Open Observational Study for Antifungal Treatment's Optimization
P4844
Q61915392-052DF484-26AB-449F-8E80-B6F000945B70Q61917969-6F438435-F970-4FB1-9423-04752D0B5ACFQ61957400-48D98498-E49E-4B75-A864-2D6B8C5CD7DBQ61957562-B31DC429-3004-4E5A-99A1-3042E3516CBDQ61969803-EDF775D2-D9D6-4A39-9BE1-97F4575B7802Q61975517-6384E867-410B-4BEE-9B8B-B9E7C39F2019Q61980367-02A0EF24-37FE-4614-BA6D-4C80A814EFB3Q62105304-092756F1-D509-486D-90EE-3D40CBBD4E26Q62105809-382754DD-7B8B-4A15-8D3E-1669DA466810Q62110976-CA368822-388E-4617-A9D6-8DA476230DF5Q63318081-EF34F0C3-078B-4997-A5BF-2EA1924549B2Q63402584-8E3CAF1A-8DFD-4344-A614-996609DA489CQ63571535-2610ADAE-924F-4835-9D29-203414F2828CQ63591958-861FFF33-FBB8-48F3-9F18-DC341B0BCBC7
P4844
description
group of stereoisomers
@en
groupe de stéréoisomères
@fr
name
Caspofungin
@de
Caspofungin
@en
Caspofungin
@nb
Caspofungin
@nl
Caspofungina
@es
Caspofungina
@pt
Caspofungină
@ro
Kaspofungin
@sh
Kaspofungin
@sr
caspoffwngin
@cy
type
label
Caspofungin
@de
Caspofungin
@en
Caspofungin
@nb
Caspofungin
@nl
Caspofungina
@es
Caspofungina
@pt
Caspofungină
@ro
Kaspofungin
@sh
Kaspofungin
@sr
caspoffwngin
@cy
altLabel
(4R,5S)-5-((2-Aminoethyl)amino ...... L-proline cyclic (6-1)-peptide
@cy
(4R,5S)-5-((2-Aminoethyl)amino ...... L-proline cyclic (6-1)-peptide
@en
1-[(4R,5S)-5-[(2-Aminoethyl)am ...... y-L-ornithine]-pneumocandin b0
@cy
1-[(4R,5S)-5-[(2-Aminoethyl)am ...... y-L-ornithine]-pneumocandin b0
@en
C52H88N10O15
@it
L-743872
@cy
L-743872
@en
MK-991
@cy
MK-991
@en
prefLabel
Caspofungin
@de
Caspofungin
@en
Caspofungin
@nb
Caspofungin
@nl
Caspofungina
@es
Caspofungina
@pt
Caspofungină
@ro
Kaspofungin
@sh
Kaspofungin
@sr
caspoffwngin
@cy
P486
P592
P6366
P646
P661
P662
P665
P117
P1579
P1748
P2017
CCC(C)CC(C)CCCCCCCCC(=O)N[C@H] ...... C4)O)O)O)[C@@H](CCN)O)O)NCCN)O
P2067
1,092.643062
P2115
N0000148694